Copyright Reports & Markets. All rights reserved.

Global Drug Transdermal Patch Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Drug Transdermal Patch Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Duragesic
    • 1.3.3 Exelon Patch
    • 1.3.4 Lindoerm
    • 1.3.5 Mohrus
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Drug Transdermal Patch Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global Drug Transdermal Patch Market Size & Forecast
    • 1.5.1 Global Drug Transdermal Patch Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Drug Transdermal Patch Sales Quantity (2021-2032)
    • 1.5.3 Global Drug Transdermal Patch Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Hisamitsu
    • 2.1.1 Hisamitsu Details
    • 2.1.2 Hisamitsu Major Business
    • 2.1.3 Hisamitsu Drug Transdermal Patch Product and Services
    • 2.1.4 Hisamitsu Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Hisamitsu Recent Developments/Updates
  • 2.2 Mylan
    • 2.2.1 Mylan Details
    • 2.2.2 Mylan Major Business
    • 2.2.3 Mylan Drug Transdermal Patch Product and Services
    • 2.2.4 Mylan Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Mylan Recent Developments/Updates
  • 2.3 GSK
    • 2.3.1 GSK Details
    • 2.3.2 GSK Major Business
    • 2.3.3 GSK Drug Transdermal Patch Product and Services
    • 2.3.4 GSK Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 GSK Recent Developments/Updates
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Drug Transdermal Patch Product and Services
    • 2.4.4 Novartis Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Novartis Recent Developments/Updates
  • 2.5 Teve (Actavis)
    • 2.5.1 Teve (Actavis) Details
    • 2.5.2 Teve (Actavis) Major Business
    • 2.5.3 Teve (Actavis) Drug Transdermal Patch Product and Services
    • 2.5.4 Teve (Actavis) Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Teve (Actavis) Recent Developments/Updates
  • 2.6 Johnson & Johnson
    • 2.6.1 Johnson & Johnson Details
    • 2.6.2 Johnson & Johnson Major Business
    • 2.6.3 Johnson & Johnson Drug Transdermal Patch Product and Services
    • 2.6.4 Johnson & Johnson Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Johnson & Johnson Recent Developments/Updates
  • 2.7 Lohmann
    • 2.7.1 Lohmann Details
    • 2.7.2 Lohmann Major Business
    • 2.7.3 Lohmann Drug Transdermal Patch Product and Services
    • 2.7.4 Lohmann Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Lohmann Recent Developments/Updates
  • 2.8 Teikoku Seiyaku
    • 2.8.1 Teikoku Seiyaku Details
    • 2.8.2 Teikoku Seiyaku Major Business
    • 2.8.3 Teikoku Seiyaku Drug Transdermal Patch Product and Services
    • 2.8.4 Teikoku Seiyaku Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Teikoku Seiyaku Recent Developments/Updates
  • 2.9 Bayer
    • 2.9.1 Bayer Details
    • 2.9.2 Bayer Major Business
    • 2.9.3 Bayer Drug Transdermal Patch Product and Services
    • 2.9.4 Bayer Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Bayer Recent Developments/Updates
  • 2.10 Lingrui
    • 2.10.1 Lingrui Details
    • 2.10.2 Lingrui Major Business
    • 2.10.3 Lingrui Drug Transdermal Patch Product and Services
    • 2.10.4 Lingrui Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Lingrui Recent Developments/Updates
  • 2.11 Sanofi
    • 2.11.1 Sanofi Details
    • 2.11.2 Sanofi Major Business
    • 2.11.3 Sanofi Drug Transdermal Patch Product and Services
    • 2.11.4 Sanofi Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Sanofi Recent Developments/Updates
  • 2.12 Zhejiang Ausun Pharmaceutical
    • 2.12.1 Zhejiang Ausun Pharmaceutical Details
    • 2.12.2 Zhejiang Ausun Pharmaceutical Major Business
    • 2.12.3 Zhejiang Ausun Pharmaceutical Drug Transdermal Patch Product and Services
    • 2.12.4 Zhejiang Ausun Pharmaceutical Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Zhejiang Ausun Pharmaceutical Recent Developments/Updates
  • 2.13 Endo International)
    • 2.13.1 Endo International) Details
    • 2.13.2 Endo International) Major Business
    • 2.13.3 Endo International) Drug Transdermal Patch Product and Services
    • 2.13.4 Endo International) Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Endo International) Recent Developments/Updates
  • 2.14 Huarun 999
    • 2.14.1 Huarun 999 Details
    • 2.14.2 Huarun 999 Major Business
    • 2.14.3 Huarun 999 Drug Transdermal Patch Product and Services
    • 2.14.4 Huarun 999 Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Huarun 999 Recent Developments/Updates
  • 2.15 Haw Par
    • 2.15.1 Haw Par Details
    • 2.15.2 Haw Par Major Business
    • 2.15.3 Haw Par Drug Transdermal Patch Product and Services
    • 2.15.4 Haw Par Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Haw Par Recent Developments/Updates
  • 2.16 Nichiban
    • 2.16.1 Nichiban Details
    • 2.16.2 Nichiban Major Business
    • 2.16.3 Nichiban Drug Transdermal Patch Product and Services
    • 2.16.4 Nichiban Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Nichiban Recent Developments/Updates
  • 2.17 Mentholatum
    • 2.17.1 Mentholatum Details
    • 2.17.2 Mentholatum Major Business
    • 2.17.3 Mentholatum Drug Transdermal Patch Product and Services
    • 2.17.4 Mentholatum Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Mentholatum Recent Developments/Updates
  • 2.18 Laboratoires Genevrier
    • 2.18.1 Laboratoires Genevrier Details
    • 2.18.2 Laboratoires Genevrier Major Business
    • 2.18.3 Laboratoires Genevrier Drug Transdermal Patch Product and Services
    • 2.18.4 Laboratoires Genevrier Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Laboratoires Genevrier Recent Developments/Updates
  • 2.19 ProStrakan
    • 2.19.1 ProStrakan Details
    • 2.19.2 ProStrakan Major Business
    • 2.19.3 ProStrakan Drug Transdermal Patch Product and Services
    • 2.19.4 ProStrakan Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 ProStrakan Recent Developments/Updates
  • 2.20 Allergan
    • 2.20.1 Allergan Details
    • 2.20.2 Allergan Major Business
    • 2.20.3 Allergan Drug Transdermal Patch Product and Services
    • 2.20.4 Allergan Drug Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Allergan Recent Developments/Updates

3 Competitive Environment: Drug Transdermal Patch by Manufacturer

  • 3.1 Global Drug Transdermal Patch Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Drug Transdermal Patch Revenue by Manufacturer (2021-2026)
  • 3.3 Global Drug Transdermal Patch Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Drug Transdermal Patch by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Drug Transdermal Patch Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Drug Transdermal Patch Manufacturer Market Share in 2025
  • 3.5 Drug Transdermal Patch Market: Overall Company Footprint Analysis
    • 3.5.1 Drug Transdermal Patch Market: Region Footprint
    • 3.5.2 Drug Transdermal Patch Market: Company Product Type Footprint
    • 3.5.3 Drug Transdermal Patch Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Drug Transdermal Patch Market Size by Region
    • 4.1.1 Global Drug Transdermal Patch Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Drug Transdermal Patch Consumption Value by Region (2021-2032)
    • 4.1.3 Global Drug Transdermal Patch Average Price by Region (2021-2032)
  • 4.2 North America Drug Transdermal Patch Consumption Value (2021-2032)
  • 4.3 Europe Drug Transdermal Patch Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Drug Transdermal Patch Consumption Value (2021-2032)
  • 4.5 South America Drug Transdermal Patch Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Drug Transdermal Patch Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Drug Transdermal Patch Sales Quantity by Type (2021-2032)
  • 5.2 Global Drug Transdermal Patch Consumption Value by Type (2021-2032)
  • 5.3 Global Drug Transdermal Patch Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Drug Transdermal Patch Sales Quantity by Application (2021-2032)
  • 6.2 Global Drug Transdermal Patch Consumption Value by Application (2021-2032)
  • 6.3 Global Drug Transdermal Patch Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Drug Transdermal Patch Sales Quantity by Type (2021-2032)
  • 7.2 North America Drug Transdermal Patch Sales Quantity by Application (2021-2032)
  • 7.3 North America Drug Transdermal Patch Market Size by Country
    • 7.3.1 North America Drug Transdermal Patch Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Drug Transdermal Patch Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Drug Transdermal Patch Sales Quantity by Type (2021-2032)
  • 8.2 Europe Drug Transdermal Patch Sales Quantity by Application (2021-2032)
  • 8.3 Europe Drug Transdermal Patch Market Size by Country
    • 8.3.1 Europe Drug Transdermal Patch Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Drug Transdermal Patch Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Drug Transdermal Patch Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Drug Transdermal Patch Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Drug Transdermal Patch Market Size by Region
    • 9.3.1 Asia-Pacific Drug Transdermal Patch Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Drug Transdermal Patch Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Drug Transdermal Patch Sales Quantity by Type (2021-2032)
  • 10.2 South America Drug Transdermal Patch Sales Quantity by Application (2021-2032)
  • 10.3 South America Drug Transdermal Patch Market Size by Country
    • 10.3.1 South America Drug Transdermal Patch Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Drug Transdermal Patch Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Drug Transdermal Patch Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Drug Transdermal Patch Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Drug Transdermal Patch Market Size by Country
    • 11.3.1 Middle East & Africa Drug Transdermal Patch Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Drug Transdermal Patch Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Drug Transdermal Patch Market Drivers
  • 12.2 Drug Transdermal Patch Market Restraints
  • 12.3 Drug Transdermal Patch Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Drug Transdermal Patch and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Drug Transdermal Patch
  • 13.3 Drug Transdermal Patch Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Drug Transdermal Patch Typical Distributors
  • 14.3 Drug Transdermal Patch Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Drug Transdermal Patch market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Transdermal therapeutic system (TTS or transdermal delivery system, TDS) or transdermal absorption preparation refers to the use of pharmaceutical, physical and chemical methods to promote the penetration of drugs at a constant rate (or close to a constant rate). It is a new dosage form that enters the circulatory system through the skin surface and produces systemic or local therapeutic effects. In a narrow sense, transdermal drug delivery forms are patches or patches; in a broad sense, TDS includes not only patches (tablets), but also ointments, plasters, liniments and aerosols, as well as non-innovative agents such as traditional patches. .
    This report is a detailed and comprehensive analysis for global Drug Transdermal Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Drug Transdermal Patch market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Drug Transdermal Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Drug Transdermal Patch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Drug Transdermal Patch market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Drug Transdermal Patch
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Drug Transdermal Patch market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Drug Transdermal Patch market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Duragesic
    Exelon Patch
    Lindoerm
    Mohrus
    Others
    Market segment by Application
    Hospital
    Clinic
    Major players covered
    Hisamitsu
    Mylan
    GSK
    Novartis
    Teve (Actavis)
    Johnson & Johnson
    Lohmann
    Teikoku Seiyaku
    Bayer
    Lingrui
    Sanofi
    Zhejiang Ausun Pharmaceutical
    Endo International)
    Huarun 999
    Haw Par
    Nichiban
    Mentholatum
    Laboratoires Genevrier
    ProStrakan
    Allergan
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Drug Transdermal Patch product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Drug Transdermal Patch, with price, sales quantity, revenue, and global market share of Drug Transdermal Patch from 2021 to 2026.
    Chapter 3, the Drug Transdermal Patch competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Drug Transdermal Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Drug Transdermal Patch market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Drug Transdermal Patch.
    Chapter 14 and 15, to describe Drug Transdermal Patch sales channel, distributors, customers, research findings and conclusion.

    Buy now